Paul Hudson, Sanofi CEO (Romuald Meigneux/Sipa via AP Images)
January 11, 2023 01:55 PM EST
Financing
Startups
R&D

Sanofi ex­tends com­mit­ment to $750M biotech start­up fund

Tyler Patchen

News Reporter

Last year, Sanofi’s ven­ture arm was very busy tak­ing the lead or par­tic­i­pat­ing in the fund­ing rounds of sev­er­al biotechs, and that ac­tiv­i­ty will not …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times